Wolverine Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,200
Closed -$1.41M 1739
2025
Q2
$1.41M Sell
16,200
-34,400
-68% -$2.92M 0.01% 612
2025
Q1
$4.55M Sell
50,600
-3,100
-6% -$277K 0.05% 315
2024
Q4
$4.29M Sell
53,700
-21,600
-29% -$1.87M 0.04% 352
2024
Q3
$6.78M Buy
75,300
+24,400
+48% +$2.05M 0.07% 250
2024
Q2
$4.01M Buy
50,900
+39,100
+331% +$3.21M 0.05% 330
2024
Q1
$1.03M Buy
+11,800
New +$1.01M 0.01% 641
2018
Q3
Sell
-25,000
Closed -$2.14M 1583
2018
Q2
$2.14M Hold
25,000
0.03% 502
2018
Q1
$2M Buy
+25,000
New +$2.06M 0.03% 533
2015
Q1
Sell
-95
Closed -$5K 2054
2014
Q4
$5K Sell
95
-54
-36% -$3.75K ﹤0.01% 1867
2014
Q3
$63K Sell
149
-2
-1% -$127 ﹤0.01% 1462
2014
Q2
$64K Buy
151
+4
+3% +$243 ﹤0.01% 1295
2014
Q1
$86K Buy
147
+89
+153% +$5.18K ﹤0.01% 1168
2013
Q4
$2K Sell
58
-10
-15% -$567 ﹤0.01% 2517
2013
Q3
$6K Sell
68
-120
-64% -$6.46K ﹤0.01% 2338
2013
Q2
$32K Buy
+188
New +$9.29K ﹤0.01% 1853

Other funds holding MDT

Wolverine Asset Management's MDT Position: Q3 2025 in Review

Wolverine Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 5,010 shares — an estimated $461K sold.

Wolverine Asset Management first reported a position in MDT in Q2 2013 and held it in 18 quarters. The position peaked at $2.83M in Q4 2024. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Wolverine Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 5,010 Medtronic shares in Q3 2025, an estimated $461K.
  • Wolverine Asset Management first reported a position in Medtronic in Q2 2013 and held it in 18 quarters.
  • Wolverine Asset Management's Medtronic position peaked at $2.83M in Q4 2024.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.